Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.22.2.2
SHARE CAPITAL (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of stock options activity

Options Outstanding

    

    

Weighted

    

Weighted

    

Average

Average

Number of

Exercise

Remaining

Aggregate

Shares Subject

Price Per

Contractual

Intrinsic Value

to Options

Share

Life (in years)

(in thousands)

Balance at December 31, 2021

 

1,204,233

$

5.56

3.6

Options granted

 

130,000

$

5.16

Options exercised

 

(800)

$

5.04

Options canceled / expired

 

(27,933)

$

6.26

Balance at June 30, 2022

 

1,305,500

$

4.99

 

3.2

 

$

242

Vested and exercisable at June 30, 2022

 

859,206

$

5.20

 

2.7

 

$

242

Schedule of stock options outstanding and exercisable

Options Outstanding

Options Exercisable

    

Weighted

    

    

    

Average

Weighted

Weighted

Remaining

Average

Average

Number of

Contractual

Exercise Price

Number

Exercise Price

Outstanding

Life (in years)

Per Share

Exercisable

Per Share

200,000

 

3.2

$

0.25

 

200,000

$

0.25

12,000

 

0.3

$

14.00

 

12,000

$

14.00

15,000

 

5.6

$

9.00

 

15,000

$

9.00

85,000

 

1.3

$

9.00

 

85,000

$

9.00

145,800

 

1.5

$

7.80

 

145,800

$

7.80

79,600

 

2.3

$

6.40

 

68,987

$

6.40

40,000

3.2

$

4.50

24,000

$

4.50

88,000

 

3.4

$

4.85

 

52,800

$

4.85

296,100

3.6

$

5.30

138,180

$

5.30

30,000

3.8

$

5.60

14,000

$

5.60

184,000

4.3

$

7.65

77,439

$

7.65

130,000

4.7

$

5.16

26,000

$

5.16

1,305,500

 

3.2

$

4.99

 

859,206

$

5.20

Schedule of assumptions were used to determine fair value of the awards

    

Six Months Ended June 30, 

 

2022

    

2021

Expected life (in years)

 

5.0

 

5.0

Risk-free interest rate

 

1.7

%  

0.4

%

Dividend yield

 

%  

%

Expected volatility

 

132

%  

91

%

Schedule of changes in stock option liability

Changes in the Company’s stock option liability for the six months ended June 30, 2022 was as follows (stated in thousands):

Balance at December 31, 2021

$

25

Gain on revaluation

 

25

Balance at June 30, 2022

$

Schedule of warrants

    

Number of Warrants outstanding

Convertible debt, warrants issued (Note 5)

 

380,874

Debenture, warrants issued (Note 5)

275,000

July 2020 private placement, warrants issued (1)

12,592

December 2020 equity financing warrants issued (1)

3,271,540

Total warrant outstanding

 

3,940,006

Consultants  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions were used to determine fair value of the awards

    

As of June 30,

As of December 31,

2022

    

2021

Risk free rate of return

1.7

%

0.4

%

Expected life

0.3

years

1.8

years

Expected volatility

127

%

186

%

Expected dividend per share

nil

nil